Targeting BCL6 in diffuse large B-cell lymphoma: what does this mean for the future treatment?

Lineage-specific functions of Bcl-6 in immunity and inflammation are mediated by distinct biochemical mechanisms

(2013) Chuanxin Huang et al.   NATURE IMMUNOLOGY

The Bcl6-SMRT/NCoR Cistrome Represses Inflammation to Attenuate Atherosclerosis

(2012) Grant D. Barish et al.   Cell Metabolism

Roles of BCL6 in normal and transformed germinal center B cells

(2012) Katia Basso et al.   IMMUNOLOGICAL REVIEWS

A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In Vivo

(2010) Leandro C. Cerchietti et al.   CANCER CELL

Aggressive Lymphomas

(2010) Georg Lenz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells

(2009) K. Basso et al.   BLOOD

BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt

(2009) P. Juszczynski et al.   BLOOD

The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL

(2009) W. Ci et al.   BLOOD

A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo

(2008) L. C. Cerchietti et al.   BLOOD

Sequential Transcription Factor Targeting for Diffuse Large B-Cell Lymphomas

(2008) L. C. Cerchietti et al.   CANCER RESEARCH

Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas

(2008) Samir Parekh et al.   LEUKEMIA & LYMPHOMA